Evaluation of the 2023 Duke–International Society of Cardiovascular Infectious Diseases Criteria in a Multicenter Cohort of Patients With Intravenous Drug Use: A Retrospective Study
The 2023 Duke-ISCVID criteria reclassified 5% of IE cases in patients with IVDU due to expanded microbiological definitions. The unexpected prevalence of <i>S. pyogenes</i> highlights the need to consider atypical pathogens in high-risk groups.
Authors
- Evin Yucel (ORCID: https://orcid.org/0000-0002-7074-6380)
- Molly L Paras (ORCID: https://orcid.org/0000-0001-6658-8634)
- Sami El‐Dalati (ORCID: https://orcid.org/0000-0003-2603-2951)
- Talal Alnabelsi (ORCID: https://orcid.org/0000-0002-0306-8911)
- Qiao Han (ORCID: https://orcid.org/0000-0001-7089-1767)
- David Henson (ORCID: https://orcid.org/0000-0003-2897-204X)
Institutions
- University of Kentucky (US)
- Massachusetts General Hospital (US)
Publication Details
- Journal
- Open Forum Infectious Diseases
- Published
- 2025-02-28
- DOI
- https://doi.org/10.1093/ofid/ofaf126
- Citations
- 1
- Primary Topic
- Infective Endocarditis Diagnosis and Management
- Type
- article
- Field-Weighted Citation Impact
- 1.35